MaryBranchMDMS

PubMed

• Overview of short and long-term management of cardiovascular disease in the cancer patient: Research-driven guidance for the clinician.
  Mary Branch> ;American Heart Journal Plus. 2023 Dec 1
• 11 citations
  Cardiotoxicity risk factors with immune checkpoint inhibitors.
  Zachary L Brumberger, Mary E Branch, Max W Klein, Austin Seals, Michael D Shapiro, Sujethra Vasu> ;Cardio-Oncology. 2022 Mar 11
• 15 citations
  Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors.
  Kerryn W Reding, Richard K Cheng, Alexi Vasbinder, Roberta M Ray, Ana Barac, Charles B Eaton, Nazmus Saquib, Aladdin H Shadyab, Michael S Simon, Dale Langford, Mary Br...> ;JACC. Cardiooncology. 2022 Mar 1
• 4 citations
  The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges
  Carolyn J Park, Mary Branch, Sujethra Vasu, Giselle C. Meléndez> ;Journal of Cardiovascular Translational Research. 2020 Apr 4
• 9 citations
  Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.
  Mary Branch, Charles A German, Alain G. Bertoni, Joseph Yeboah> ;Journal of Diabetes and Its Complications. 2019 Jul 1
• 48 citations
  Cardiovascular Effects of the MEK Inhibitor, Trametinib: A Case Report, Literature Review, and Consideration of Mechanism
  Mary Banks, Karen Crowell, Amber Proctor, Brian C. Jensen> ;Cardiovascular Toxicology. 2017 Oct 1
• Intensity of vascular catheter use in critical care: impact on catheter-associated bloodstream infection rates and association with severity of illness.
  Fong, K. S., Banks, M., Benish, R., Fatica, C., Triche, M., Smith, N., Butler, R., Gordon, S. M., Fraser, T. G.> ;Infect Control Hosp Epidemiol. 2012 Dec
• Join now to see all